WO2017114372A1 - Chinese patent medicine for treating gastroenteritis and preparation method therefor - Google Patents
Chinese patent medicine for treating gastroenteritis and preparation method therefor Download PDFInfo
- Publication number
- WO2017114372A1 WO2017114372A1 PCT/CN2016/112236 CN2016112236W WO2017114372A1 WO 2017114372 A1 WO2017114372 A1 WO 2017114372A1 CN 2016112236 W CN2016112236 W CN 2016112236W WO 2017114372 A1 WO2017114372 A1 WO 2017114372A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- parts
- chinese patent
- patent medicine
- gastroenteritis
- dog
- Prior art date
Links
- 239000003814 drug Substances 0.000 title claims abstract description 48
- 208000005577 Gastroenteritis Diseases 0.000 title claims abstract description 22
- 238000002360 preparation method Methods 0.000 title description 5
- GXCLVBGFBYZDAG-UHFFFAOYSA-N N-[2-(1H-indol-3-yl)ethyl]-N-methylprop-2-en-1-amine Chemical compound CN(CCC1=CNC2=C1C=CC=C2)CC=C GXCLVBGFBYZDAG-UHFFFAOYSA-N 0.000 claims abstract description 15
- 239000002994 raw material Substances 0.000 claims abstract description 12
- 244000042430 Rhodiola rosea Species 0.000 claims abstract 2
- 235000003713 Rhodiola rosea Nutrition 0.000 claims abstract 2
- 241000185686 Apocynum venetum Species 0.000 claims description 14
- 244000035851 Chrysanthemum leucanthemum Species 0.000 claims description 14
- 235000008495 Chrysanthemum leucanthemum Nutrition 0.000 claims description 14
- 241000209140 Triticum Species 0.000 claims description 14
- 235000021307 Triticum Nutrition 0.000 claims description 14
- 241001165494 Rhodiola Species 0.000 claims description 13
- 244000236658 Paeonia lactiflora Species 0.000 claims description 11
- 235000008598 Paeonia lactiflora Nutrition 0.000 claims description 11
- 235000011389 fruit/vegetable juice Nutrition 0.000 claims description 10
- 238000010438 heat treatment Methods 0.000 claims description 10
- 239000000843 powder Substances 0.000 claims description 10
- 239000000203 mixture Substances 0.000 claims description 8
- 238000003756 stirring Methods 0.000 claims description 8
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 8
- 241000009328 Perro Species 0.000 claims description 5
- 241000405217 Viola <butterfly> Species 0.000 claims description 5
- 239000007864 aqueous solution Substances 0.000 claims description 5
- 239000012153 distilled water Substances 0.000 claims description 5
- 239000011812 mixed powder Substances 0.000 claims description 5
- 239000011259 mixed solution Substances 0.000 claims description 5
- 239000008188 pellet Substances 0.000 claims description 5
- 244000166124 Eucalyptus globulus Species 0.000 claims 4
- 238000004519 manufacturing process Methods 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 16
- 201000010099 disease Diseases 0.000 abstract description 13
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract description 13
- 201000006549 dyspepsia Diseases 0.000 abstract description 7
- 206010000060 Abdominal distension Diseases 0.000 abstract description 6
- 210000004185 liver Anatomy 0.000 abstract description 6
- 208000024330 bloating Diseases 0.000 abstract description 5
- 230000002496 gastric effect Effects 0.000 abstract description 5
- 208000002551 irritable bowel syndrome Diseases 0.000 abstract description 5
- 210000002784 stomach Anatomy 0.000 abstract description 5
- 241000405414 Rehmannia Species 0.000 abstract description 4
- 206010047700 Vomiting Diseases 0.000 abstract description 4
- 206010010774 Constipation Diseases 0.000 abstract description 3
- 235000013305 food Nutrition 0.000 abstract description 3
- 230000008673 vomiting Effects 0.000 abstract description 3
- 239000008186 active pharmaceutical agent Substances 0.000 abstract description 2
- 230000029087 digestion Effects 0.000 abstract description 2
- 230000000144 pharmacologic effect Effects 0.000 abstract description 2
- 230000001737 promoting effect Effects 0.000 abstract 2
- 241001643995 Albizia chinensis Species 0.000 abstract 1
- 241000425308 Begonia fimbristipula Species 0.000 abstract 1
- 241000628997 Flos Species 0.000 abstract 1
- 230000002411 adverse Effects 0.000 abstract 1
- 230000014759 maintenance of location Effects 0.000 abstract 1
- 231100000956 nontoxicity Toxicity 0.000 abstract 1
- 208000024891 symptom Diseases 0.000 description 26
- 230000001684 chronic effect Effects 0.000 description 11
- 229940079593 drug Drugs 0.000 description 11
- 206010012735 Diarrhoea Diseases 0.000 description 10
- 241000219927 Eucalyptus Species 0.000 description 10
- 238000000034 method Methods 0.000 description 8
- 210000003097 mucus Anatomy 0.000 description 6
- 208000018522 Gastrointestinal disease Diseases 0.000 description 5
- 244000020551 Helianthus annuus Species 0.000 description 5
- 235000003222 Helianthus annuus Nutrition 0.000 description 5
- 208000018556 stomach disease Diseases 0.000 description 5
- 208000004998 Abdominal Pain Diseases 0.000 description 4
- 238000009833 condensation Methods 0.000 description 4
- 230000005494 condensation Effects 0.000 description 4
- 230000007812 deficiency Effects 0.000 description 4
- 210000000952 spleen Anatomy 0.000 description 4
- 206010000087 Abdominal pain upper Diseases 0.000 description 3
- 208000007882 Gastritis Diseases 0.000 description 3
- 210000004369 blood Anatomy 0.000 description 3
- 239000008280 blood Substances 0.000 description 3
- 208000023652 chronic gastritis Diseases 0.000 description 3
- 201000000117 functional diarrhea Diseases 0.000 description 3
- 229960004503 metoclopramide Drugs 0.000 description 3
- TTWJBBZEZQICBI-UHFFFAOYSA-N metoclopramide Chemical compound CCN(CC)CCNC(=O)C1=CC(Cl)=C(N)C=C1OC TTWJBBZEZQICBI-UHFFFAOYSA-N 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- 230000001225 therapeutic effect Effects 0.000 description 3
- GHOKWGTUZJEAQD-ZETCQYMHSA-N (D)-(+)-Pantothenic acid Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-ZETCQYMHSA-N 0.000 description 2
- 206010012742 Diarrhoea infectious Diseases 0.000 description 2
- 206010019233 Headaches Diseases 0.000 description 2
- 206010019909 Hernia Diseases 0.000 description 2
- 206010020751 Hypersensitivity Diseases 0.000 description 2
- 206010028813 Nausea Diseases 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 238000002583 angiography Methods 0.000 description 2
- 230000003474 anti-emetic effect Effects 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- DCSUBABJRXZOMT-IRLDBZIGSA-N cisapride Chemical compound C([C@@H]([C@@H](CC1)NC(=O)C=2C(=CC(N)=C(Cl)C=2)OC)OC)N1CCCOC1=CC=C(F)C=C1 DCSUBABJRXZOMT-IRLDBZIGSA-N 0.000 description 2
- 229960005132 cisapride Drugs 0.000 description 2
- DCSUBABJRXZOMT-UHFFFAOYSA-N cisapride Natural products C1CC(NC(=O)C=2C(=CC(N)=C(Cl)C=2)OC)C(OC)CN1CCCOC1=CC=C(F)C=C1 DCSUBABJRXZOMT-UHFFFAOYSA-N 0.000 description 2
- 208000002173 dizziness Diseases 0.000 description 2
- 239000003210 dopamine receptor blocking agent Substances 0.000 description 2
- 208000001848 dysentery Diseases 0.000 description 2
- 210000003608 fece Anatomy 0.000 description 2
- 210000001156 gastric mucosa Anatomy 0.000 description 2
- 231100000869 headache Toxicity 0.000 description 2
- 230000000968 intestinal effect Effects 0.000 description 2
- 230000003902 lesion Effects 0.000 description 2
- 230000007774 longterm Effects 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 230000008693 nausea Effects 0.000 description 2
- 239000002547 new drug Substances 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- 238000007619 statistical method Methods 0.000 description 2
- YPELFRMCRYSPKZ-UHFFFAOYSA-N 4-amino-5-chloro-2-ethoxy-N-({4-[(4-fluorophenyl)methyl]morpholin-2-yl}methyl)benzamide Chemical compound CCOC1=CC(N)=C(Cl)C=C1C(=O)NCC1OCCN(CC=2C=CC(F)=CC=2)C1 YPELFRMCRYSPKZ-UHFFFAOYSA-N 0.000 description 1
- 108091005482 5-HT4 receptors Proteins 0.000 description 1
- 206010067484 Adverse reaction Diseases 0.000 description 1
- 241000208838 Asteraceae Species 0.000 description 1
- 208000037157 Azotemia Diseases 0.000 description 1
- 206010008469 Chest discomfort Diseases 0.000 description 1
- GHOKWGTUZJEAQD-UHFFFAOYSA-N Chick antidermatitis factor Natural products OCC(C)(C)C(O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-UHFFFAOYSA-N 0.000 description 1
- 208000002881 Colic Diseases 0.000 description 1
- 229940121891 Dopamine receptor antagonist Drugs 0.000 description 1
- 206010059186 Early satiety Diseases 0.000 description 1
- 208000010201 Exanthema Diseases 0.000 description 1
- 206010017999 Gastrointestinal pain Diseases 0.000 description 1
- 241000208152 Geranium Species 0.000 description 1
- 208000019025 Hypokalemia Diseases 0.000 description 1
- 206010021639 Incontinence Diseases 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 208000002193 Pain Diseases 0.000 description 1
- 208000003251 Pruritus Diseases 0.000 description 1
- 208000032023 Signs and Symptoms Diseases 0.000 description 1
- 208000007107 Stomach Ulcer Diseases 0.000 description 1
- 208000001871 Tachycardia Diseases 0.000 description 1
- 206010000059 abdominal discomfort Diseases 0.000 description 1
- 238000007792 addition Methods 0.000 description 1
- 230000006838 adverse reaction Effects 0.000 description 1
- 208000026935 allergic disease Diseases 0.000 description 1
- 239000002111 antiemetic agent Substances 0.000 description 1
- 230000004596 appetite loss Effects 0.000 description 1
- 201000010878 atypical lipomatous tumor Diseases 0.000 description 1
- 229910052788 barium Inorganic materials 0.000 description 1
- DSAJWYNOEDNPEQ-UHFFFAOYSA-N barium atom Chemical compound [Ba] DSAJWYNOEDNPEQ-UHFFFAOYSA-N 0.000 description 1
- 150000001556 benzimidazoles Chemical class 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 208000027503 bloody stool Diseases 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 230000001713 cholinergic effect Effects 0.000 description 1
- CCGSUNCLSOWKJO-UHFFFAOYSA-N cimetidine Chemical compound N#CNC(=N/C)\NCCSCC1=NC=N[C]1C CCGSUNCLSOWKJO-UHFFFAOYSA-N 0.000 description 1
- 229960001380 cimetidine Drugs 0.000 description 1
- 210000001072 colon Anatomy 0.000 description 1
- 230000000112 colonic effect Effects 0.000 description 1
- 238000002052 colonoscopy Methods 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 208000010643 digestive system disease Diseases 0.000 description 1
- FGXWKSZFVQUSTL-UHFFFAOYSA-N domperidone Chemical compound C12=CC=CC=C2NC(=O)N1CCCN(CC1)CCC1N1C2=CC=C(Cl)C=C2NC1=O FGXWKSZFVQUSTL-UHFFFAOYSA-N 0.000 description 1
- 229960001253 domperidone Drugs 0.000 description 1
- 229940088679 drug related substance Drugs 0.000 description 1
- 230000002183 duodenal effect Effects 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 230000002996 emotional effect Effects 0.000 description 1
- 230000002124 endocrine Effects 0.000 description 1
- 238000001839 endoscopy Methods 0.000 description 1
- 210000003743 erythrocyte Anatomy 0.000 description 1
- 210000003238 esophagus Anatomy 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 201000005884 exanthem Diseases 0.000 description 1
- 230000007717 exclusion Effects 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 235000019525 fullness Nutrition 0.000 description 1
- 230000030135 gastric motility Effects 0.000 description 1
- 208000021302 gastroesophageal reflux disease Diseases 0.000 description 1
- 230000005176 gastrointestinal motility Effects 0.000 description 1
- 208000035861 hematochezia Diseases 0.000 description 1
- 235000003642 hunger Nutrition 0.000 description 1
- 230000009610 hypersensitivity Effects 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 230000008991 intestinal motility Effects 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- 230000007803 itching Effects 0.000 description 1
- 150000002576 ketones Chemical class 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 210000000265 leukocyte Anatomy 0.000 description 1
- 208000019423 liver disease Diseases 0.000 description 1
- 208000019017 loss of appetite Diseases 0.000 description 1
- 235000021266 loss of appetite Nutrition 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 229960004085 mosapride Drugs 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 229940055726 pantothenic acid Drugs 0.000 description 1
- 235000019161 pantothenic acid Nutrition 0.000 description 1
- 239000011713 pantothenic acid Substances 0.000 description 1
- 230000002093 peripheral effect Effects 0.000 description 1
- 208000024896 potassium deficiency disease Diseases 0.000 description 1
- 208000037920 primary disease Diseases 0.000 description 1
- 210000004915 pus Anatomy 0.000 description 1
- 206010037844 rash Diseases 0.000 description 1
- 239000000018 receptor agonist Substances 0.000 description 1
- 229940044601 receptor agonist Drugs 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 238000010079 rubber tapping Methods 0.000 description 1
- 238000013077 scoring method Methods 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 230000009747 swallowing Effects 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 238000012353 t test Methods 0.000 description 1
- 230000006794 tachycardia Effects 0.000 description 1
- 229940126585 therapeutic drug Drugs 0.000 description 1
- 238000012549 training Methods 0.000 description 1
- 208000009852 uremia Diseases 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 238000013022 venting Methods 0.000 description 1
- 208000022752 well-differentiated liposarcoma Diseases 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/41—Crassulaceae (Stonecrop family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/11—Pteridophyta or Filicophyta (ferns)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/232—Angelica
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/24—Apocynaceae (Dogbane family), e.g. plumeria or periwinkle
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/287—Chrysanthemum, e.g. daisy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/80—Scrophulariaceae (Figwort family)
- A61K36/804—Rehmannia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/899—Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/899—Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
- A61K36/8998—Hordeum (barley)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation or decoction
Definitions
- the present invention relates to a proprietary Chinese medicine for gastroenteritis and a preparation method thereof, and belongs to the field of traditional Chinese medicine.
- Chronic stomach disease is a common clinical disease, and belongs to the category of diseases such as “stomach cramps”, “small fullness”, “swallowing acid”, “noisy”, and “nano-stasis”.
- Chinese medicine believes that chronic gastritis is caused by long-term emotional uneasiness, unhealthy diet, and disordered work, leading to liver qi stagnation, spleen loss and health, and stomach stagnation, and long-term qi deficiency, which causes various symptoms.
- the main symptoms of chronic gastritis are stomach acid, bloating, stomach pain, and some may cause indigestion.
- Other patients have hunger, chest tightness, tapping the back (ie, back sinking), and stomach ulcers.
- the main clinical manifestations of chronic gastritis are loss of appetite, upper abdominal discomfort and dull pain, hernia, pantothenic acid, nausea, vomiting and the like.
- the drugs for clinical treatment of this disease are roughly divided into two categories: protection of gastric mucosa and elimination of drugs that damage the gastric mucosa, such as gastrointestinal ketone, gaipipine, cimetidine, metoclopramide, etc.
- There are obvious side effects such as diarrhea, headache, dizziness, edema, and hypokalemia, and the effect is single, the efficiency is low, and the recurrence is easy after the treatment.
- the first generation, such as metoclopramide is a dopamine receptor antagonist with cholinergic characteristics.
- Metoclopramide has an injection and has an antiemetic effect, and is currently used as an antiemetic in clinical practice.
- the second generation of prokinetic drugs is domperidone, which is a peripheral dopamine receptor blocker. It is widely used clinically, mainly to promote gastric motility, but the intestinal motility is not good.
- the third generation is cisapride, a mesoclopramide that chemically replaces alkylated benzimidazole.
- QT interval prolongation or tip torsion may occur in patients with cisapride hypersensitivity.
- the tachycardia is still controversial for its further clinical application.
- the fourth generation is mosapride, a non-selective 5-HT4 receptor agonist, a novel gastrointestinal motility drug.
- Relatively safe, adverse reactions are usually stomach or esophagus and abdominal cramps, intestinal cramps, diarrhea, abdominal pain, occasional dizziness, nausea, headache, ALT, AST rise, itching, rash and other allergic reactions, and the price is more expensive.
- Chinese medicine believes that stomach diseases are often caused by liver fire or spleen deficiency. The main treatment for stomach diseases lies in strong liver and spleen. In modern society, due to overwork, a common chronic stomach disease caused by spleen deficiency.
- the technical problem to be solved by the present invention is to provide a proprietary Chinese medicine for gastroenteritis and a preparation method thereof for treating irritable bowel syndrome, functional dyspepsia, and function Chronic stomach diseases such as bloating and functional constipation have remarkable curative effects, and are low in cost and safe to use.
- the technical solution adopted by the present invention is a Chinese patent medicine for gastroenteritis, which is prepared from the following raw materials by weight: 10-17 parts of Rhodiola, purple-backed sunflower 8-10 parts, 5-10 parts of Apocynum venetum, 5-10 parts of dog ridge, 3-7 parts of wild chrysanthemum, 5-9 parts of eucalyptus, 10-15 parts of fried malt, 3-6 parts of rehmannia, floating wheat 2 -6 parts, 150-200 parts of white peony.
- the above-mentioned proprietary Chinese medicine for gastroenteritis is made up of the following raw materials by weight: 13 parts of Rhodiola, 9 parts of Asteraceae, 7 parts of Apocynum venetum, 7.5 parts of dog ridge, Wild chrysanthemum 4.5 7.5 parts of eucalyptus, 13 parts of fried malt, 5 parts of rehmannia, 4.2 parts of floating wheat, and 180 parts of white peony.
- a method for preparing a proprietary Chinese medicine for gastroenteritis is prepared by the following steps: (1) Rhodiola, Viola, Apocynum venetum, dog ridge, wild chrysanthemum, eucalyptus, rehmannia and The floating wheat is ground into a powder and stirred evenly; (2) Take half of the mixed powder of step (1) into distilled water and soak for 30-60 hours; (3) heat the aqueous solution completed in step (2), the heating temperature is low.
- the heated steam is condensed and recovered; (4) The other half of the powder of step (1) is placed in a chalk, heated at 60 ° C for 2.5 hours, and the juice is removed; (5) Step (4) The completed juice is mixed with the condensate recovered in the step (3), and then mixed and stirred twice; (6) The mixed solution obtained in the step (5) is added with fried malt, and stirred at a temperature of 50 ° C. After heating, after removing moisture, the paste mixture is kneaded into a pellet and then wax-sealed.
- the Chinese patent medicine group of the invention is derived from commonly used traditional Chinese medicine components, and is mostly a medicine and food product, the raw material is cheap, the preparation is simple, the use is convenient, and after many years of clinical application and pharmacological research, the treatment of intestinal irritation Syndrome, work Gastrointestinal functional lesions such as dyspepsia, functional bloating, and functional constipation have significant curative effects; the drug substance plays a role in eliminating digestion and stomach, reducing vomiting, venting qi, eliminating liver and qi, Gastroenteritis caused by various reasons has a good curative effect; in view of the large number of cases of the disease, and the proprietary Chinese medicine of the present invention has the characteristics of being non-toxic and can be taken for a long time, it has broad market prospects.
- Example 1 The present invention is a proprietary Chinese medicine for gastroenteritis, which is prepared from the following raw materials by weight: 10 parts of Rhodiola, 8 parts of Viola, and 5 parts of Apocynum venetum L., dog 5 parts of ridge, 3 parts of wild chrysanthemum, 5 parts of eucalyptus, 10 parts of fried malt, 3 parts of cooked land, 2 parts of floating wheat, and 150 parts of white peony.
- a method for preparing a proprietary Chinese medicine for gastroenteritis which is prepared by the following steps: (1) Rhodiola, purple-backed sunflower, Apocynum venetum, dog ridge, wild chrysanthemum, eucalyptus, radix and floating wheat Powder, stir well; (2) Take half of the mixed powder of step (1) into distilled water and soak for 45 hours; (3) Heat the aqueous solution completed in step (2), heat at 75 ° C, and heat Steam condensation recovery; (4) Put the other half of the powder of step (1) into the chalk, heat it at 60 °C for 2.5 hours, and remove the juice; (5) Prepare the juice of step (4) and In step (3), the condensate recovered by condensation is mixed, and then mixed and stirred under heating; (6) adding the fried malt to the mixed solution obtained in the step (5), stirring and heating at a temperature of 50 ° C to remove water. The paste mixture was kneaded into a pellet and then wax sealed.
- the beneficial effects of the medicament of the present invention are further illustrated by the summary of clinically validated cases of 100 cases of chronic gastrointestinal diseases treated with the medicament of the present invention.
- the medicament of the present invention used in the following test was prepared in accordance with the method of Example 1.
- Symptom scoring method (1) Asymptomatic (-): 0 points; (2) Mild (+): Occasionally 1 point; [0019] (3) Moderate (++) : 2 points are often recorded; (4) Severe (+++): 3 points are persisted.
- Asymptomatic and softening 0 points per day 1-2 times; (2) Mild (+): mild symptoms, does not affect life and work, can endure, stool daily 2-3 times, 1 point for paste or mucus; (3) Moderate (++): The symptoms are heavy, have affected work and life, can still bear, stool is egg pattern, 4-5 times a day , or mucus will be moderately recorded 2 points; (4) severe (+++): severe symptoms, hinder work and life, unbearable, dilute watery stool, more than 6 times a day, or a large amount of 3 points of mucus.
- stool shape such as pus and bloody stools, mucus and thin water.
- routine examination of stool the number of red blood cells, white blood cells and pus cells in the stool, whether or not to digest food fiber, fat droplets, etc.
- Some patients do the training.
- Some patients underwent colonoscopy, intestinal angiography, and gastroscope.
- Functional diarrhea diarrhea, accompanied by urgency, watery stools, mucus.
- Functional dyspepsia upper abdominal fullness, early satiety, hernia, upper abdominal pain, nausea and vomiting, acid reflux.
- Irritable bowel syndrome abdominal pain, bloating, diarrhea, incontinence, stool frequency, shape.
- Chronic infectious diarrhea diarrhea, abdominal pain, urgency and heavy, mucus and blood.
- the count data is applied to the X2 test, and the measurement data is applied to the t test.
- the Chinese patent medicine of the invention has a good therapeutic effect on various chronic gastrointestinal diseases.
- the present invention is a proprietary Chinese medicine for gastroenteritis, which is prepared from the following raw materials by weight: Rhodiola 17 parts, Purple geranium 10 parts, Apocynum venetum 10 parts, dog 10 parts of ridges, 7 parts of wild chrysanthemums, 9 parts of eucalyptus, 15 parts of fried malt, 6 parts of cooked land, 6 parts of floating wheat, and 200 parts of white peony.
- a method for preparing a proprietary Chinese medicine for gastroenteritis which is prepared by the following steps: (1) Rhodiola, purple-backed sunflower, Apocynum venetum, dog ridge, wild chrysanthemum, eucalyptus, radix and floating wheat Powder, stir well; (2) Take half of the mixed powder of step (1) into distilled water, soak for 30 hours; (3) Heat the aqueous solution completed in step (2), The heating temperature is 78 degrees Celsius, and the heated steam is condensed and recovered; (4) The other half of the powder of the step (1) is placed in 180 parts of white peony, heated at 60 degrees Celsius for 2.5 hours, and the medicinal juice is taken out; Mixing the juice completed in step (4) with the condensate recovered in step (3), mixing and heating and stirring; (6) adding the fried malt to the mixed solution obtained in step (5), stirring The mixture was heated at a temperature of 50 ° C, and after removing moisture, the paste mixture was kneaded into a pellet and then wax-sealed.
- the present invention is a proprietary Chinese medicine for gastroenteritis, which is prepared from the following raw materials by weight: 13 parts of Rhodiola, 9 parts of Viola, and 7 parts of Apocynum venetum L., dog 7.5 parts of ridges, 4.5 parts of wild chrysanthemums, 7.5 parts of eucalyptus, 13 parts of fried malt, 5 parts of cooked land, 4.2 parts of floating wheat, and 180 parts of white peony.
- a method for preparing a proprietary Chinese medicine for gastroenteritis which is prepared by the following steps: (1) Rhodiola, purple-backed sunflower, Apocynum venetum, dog ridge, wild chrysanthemum, eucalyptus, radix and floating wheat Powder, stir evenly; (2) Take half of the mixed powder of step (1) into distilled water and soak for 60 hours; (3) Heat the aqueous solution completed in step (2), heat at 70 ° C, and heat Steam condensation recovery; (4) Put the other half of the powder of step (1) into 180 parts of white peony, heat it at 60 degrees Celsius for 2.5 hours, and remove the medicinal juice; (5) Complete the step (4) The medicinal juice is mixed with the condensate recovered by the condensation in the step (3), and then mixed and heated and stirred twice; (6) adding the fried malt to the mixed solution obtained in the step (5), stirring and heating at a temperature of 50 ° C. After removing the moisture, the paste mixture was kneaded into a pellet and then wax-sealed.
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Alternative & Traditional Medicine (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Medical Informatics (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
A Chinese patent medicine for treating gastroenteritis is prepared from the following raw materials in parts by weight: 10 to 17 parts of rhodiola rosea, 8 to 10 parts of begonia fimbristipula hance, 5 to 10 parts of folium apocyni veneti, 5 to 10 parts of rhizoma cibotii, 3 to 7 parts of flos chrysanthemi indici, 5 to 9 parts of albizia chinensis, 10 to 15 parts of colored malt, 3 to 6 parts of prepared rhizome of rehmannia, 2 to 6 parts of fructus tritici levis, and 150 to 200 parts of radix angelicae. The Chinese patent medicine is formed by common traditional Chinese medicine components that are mostly medicinal and edible ones, raw materials are cheap, and the Chinese patent medicine is easy to prepare and convenient to use; according to years of clinical application and pharmacological study, the Chinese patent medicine has a remarkable curative effect on gastrointestinal functional diseases such as irritable bowel syndrome, functional dyspepsia, functional bloating and functional constipation; active pharmaceutical ingredients together allow implementing the functions of promoting digestion and harmonizing stomach, descending adverse qi and arresting vomiting, promoting qi circulation and removing food retention and soothing liver and lowering qi and has a good curative effect on gastroenteritis caused by various reasons; and given the large quantity of patients suffering from the gastroenteritis and the characteristics of the Chinese patent medicine of non-toxicity and capability of being taken for a long time, the Chinese patent medicine has a broad market prospect.
Description
一种用于胃肠炎的中成药及其制备方法 技术领域 Chinese patent medicine for gastroenteritis and preparation method thereof
[0001] 本发明涉及一种用于胃肠炎的中成药及其制备方法, 属于中医药领域。 [0001] The present invention relates to a proprietary Chinese medicine for gastroenteritis and a preparation method thereof, and belongs to the field of traditional Chinese medicine.
背景技术 Background technique
[0002] 慢性胃病是临床常见病, 属中医学"胃脘痛"、 "痞满"、 "吞酸"、 "嘈杂"、 "纳呆 "等病范畴。 中医认为, 慢性胃炎多因长期情志不遂、 饮食不节、 劳逸失常, 导 致肝气郁结、 脾失健运、 胃脘失和, 日久中气亏虚, 从而引发种种症状。 慢性 胃炎的主要症状有胃酸、 胃胀、 胃痛, 有的会出现消化不良, 还有的病人出现 易饥饿、 胸闷、 攻脊梁 (也就是后背沉)、 胃溃疡。 慢性胃炎的主要临床表现为食 欲减退、 上腹部不适和隐痛、 嗳气、 泛酸、 恶心、 呕吐等。 目前, 临床上西医 治疗这种病的药物大体分为两类: 保护胃黏膜及消除损害胃黏膜的药物, 比如 生胃酮、 盖胃平、 西咪替丁、 胃复安等, 但这两类药物明显存在着腹泻、 头痛 、 眩晕、 水肿、 低血钾等明显副作用, 且疗效单一, 有效率低, 愈后易复发。 第一代如甲氧氯普胺, 是具有胆碱能特征的多巴胺受体拮抗剂, 因有较多的中 枢性副反应, 目前已经被二、 三、 四代促动力药所代替, 但由于甲氧氯普胺有 注射剂, 并有止吐作用, 临床上目前多作为止吐药使用。 第二代促动力药是多 潘立酮, 为外周多巴胺受体阻滞剂, 临床应用广泛, 主要以促胃动力为主, 但 促肠动力作用欠佳。 第三代是西沙必利, 是一种化学结构上取代了烷化苯丙咪 唑的甲氢氯普胺, 但近年临床发现在西沙必利高敏患者中可出现 Q-T间期延长或 导致尖端扭转性心动过速, 对于其在临床进一步应用, 还有着很大的争议。 第 四代为莫沙必利, 为非选择性 5-HT4受体激动剂, 是新型促胃肠动力药物。 相对 较为安全, 不良反应常见有胃或食管及腹部痉挛、 肠呜、 腹泻、 腹痛, 偶见头 晕、 恶心、 头痛、 ALT、 AST上升、 瘙痒感、 皮疹等过敏反应, 且价格较贵。 并且中医认为胃部疾病常由肝火旺盛或者脾虚引起, 治疗胃部疾病首要在于强 肝健脾。 现代社会中由于过度劳累常见的是脾虚引起的慢性胃部疾病。 [0002] Chronic stomach disease is a common clinical disease, and belongs to the category of diseases such as "stomach cramps", "small fullness", "swallowing acid", "noisy", and "nano-stasis". Chinese medicine believes that chronic gastritis is caused by long-term emotional uneasiness, unhealthy diet, and disordered work, leading to liver qi stagnation, spleen loss and health, and stomach stagnation, and long-term qi deficiency, which causes various symptoms. The main symptoms of chronic gastritis are stomach acid, bloating, stomach pain, and some may cause indigestion. Other patients have hunger, chest tightness, tapping the back (ie, back sinking), and stomach ulcers. The main clinical manifestations of chronic gastritis are loss of appetite, upper abdominal discomfort and dull pain, hernia, pantothenic acid, nausea, vomiting and the like. At present, the drugs for clinical treatment of this disease are roughly divided into two categories: protection of gastric mucosa and elimination of drugs that damage the gastric mucosa, such as gastrointestinal ketone, gaipipine, cimetidine, metoclopramide, etc. There are obvious side effects such as diarrhea, headache, dizziness, edema, and hypokalemia, and the effect is single, the efficiency is low, and the recurrence is easy after the treatment. The first generation, such as metoclopramide, is a dopamine receptor antagonist with cholinergic characteristics. It has been replaced by second, third and fourth generation prokinetic drugs because of more central side effects. Metoclopramide has an injection and has an antiemetic effect, and is currently used as an antiemetic in clinical practice. The second generation of prokinetic drugs is domperidone, which is a peripheral dopamine receptor blocker. It is widely used clinically, mainly to promote gastric motility, but the intestinal motility is not good. The third generation is cisapride, a mesoclopramide that chemically replaces alkylated benzimidazole. However, in recent years, it has been found that QT interval prolongation or tip torsion may occur in patients with cisapride hypersensitivity. The tachycardia is still controversial for its further clinical application. The fourth generation is mosapride, a non-selective 5-HT4 receptor agonist, a novel gastrointestinal motility drug. Relatively safe, adverse reactions are usually stomach or esophagus and abdominal cramps, intestinal cramps, diarrhea, abdominal pain, occasional dizziness, nausea, headache, ALT, AST rise, itching, rash and other allergic reactions, and the price is more expensive. And Chinese medicine believes that stomach diseases are often caused by liver fire or spleen deficiency. The main treatment for stomach diseases lies in strong liver and spleen. In modern society, due to overwork, a common chronic stomach disease caused by spleen deficiency.
技术问题
[0003] 针对现有技术存在的不足, 本发明所要解决的技术问题是, 提供一种用于胃肠 炎的中成药及其制备方法, 对治疗肠易激综合征、 功能性消化不良、 功能性腹 胀、 功能性便秘等慢性胃病具有显著的疗效, 而且成本低廉、 使用安全。 technical problem [0003] In view of the deficiencies of the prior art, the technical problem to be solved by the present invention is to provide a proprietary Chinese medicine for gastroenteritis and a preparation method thereof for treating irritable bowel syndrome, functional dyspepsia, and function Chronic stomach diseases such as bloating and functional constipation have remarkable curative effects, and are low in cost and safe to use.
问题的解决方案 Problem solution
技术解决方案 Technical solution
[0004] 为解决上述技术问题, 本发明采取的技术方案是, 一种用于胃肠炎的中成药, 由以下重量份数的原料制成: 红景天 10-17份、 紫背天葵 8-10份、 罗布麻叶 5-10 份、 狗脊 5-10份、 野菊花 3-7份、 楹树 5-9份、 炒麦芽 10-15份、 熟地 3-6份、 浮小 麦 2-6份、 白芷 150-200份。 [0004] In order to solve the above technical problem, the technical solution adopted by the present invention is a Chinese patent medicine for gastroenteritis, which is prepared from the following raw materials by weight: 10-17 parts of Rhodiola, purple-backed sunflower 8-10 parts, 5-10 parts of Apocynum venetum, 5-10 parts of dog ridge, 3-7 parts of wild chrysanthemum, 5-9 parts of eucalyptus, 10-15 parts of fried malt, 3-6 parts of rehmannia, floating wheat 2 -6 parts, 150-200 parts of white peony.
[0005] 优化的, 上述用于胃肠炎的中成药, 由以下重量份数的原料制成: 红景天 12-1 4份、 紫背天葵 8.5-9.5份、 罗布麻叶 6.5-7.5份、 狗脊 7-9份、 野菊花 4-6份、 楹树 6- 8份、 炒麦芽 12-14份、 熟地 4.5-5.5份、 浮小麦 3-5.5份、 白芷 160-190份。 优化的 , 上述用于胃肠炎的中成药, 由以下重量份数的原料制成: 红景天 13份、 紫背 天葵 9份、 罗布麻叶 7份、 狗脊 7.5份、 野菊花 4.5份、 楹树 7.5份、 炒麦芽 13份、 熟 地 5份、 浮小麦 4.2份、 、 白芷 180份。 [0005] Optimized, the above-mentioned proprietary Chinese medicine for gastroenteritis is prepared from the following raw materials by weight: Rhodiola 12-1 4 parts, Purple-backed sunflower 8.5-9.5 parts, Apocynum venetum 6.5-7.5 Servings, 7-9 portions of dog ridges, 4-6 parts of wild chrysanthemums, 6-8 parts of eucalyptus, 12-14 parts of fried malt, 4.5-5.5 parts of cooked land, 3-5.5 parts of floating wheat, and 160-190 parts of white peony. Optimized, the above-mentioned proprietary Chinese medicine for gastroenteritis is made up of the following raw materials by weight: 13 parts of Rhodiola, 9 parts of Asteraceae, 7 parts of Apocynum venetum, 7.5 parts of dog ridge, Wild chrysanthemum 4.5 7.5 parts of eucalyptus, 13 parts of fried malt, 5 parts of rehmannia, 4.2 parts of floating wheat, and 180 parts of white peony.
[0006] 一种用于胃肠炎的中成药的制作方法, 由以下步骤制成: (1) 红景天、 紫背 天葵、 罗布麻叶、 狗脊、 野菊花、 楹树、 熟地和浮小麦研磨成粉末, 搅拌均匀 ; (2) 取一半步骤 (1) 的混合粉末放入蒸馏水中, 浸泡 30-60小吋; (3) 将步 骤 (2) 完成的水溶液进行加热, 加热温度低于 80摄氏度, 将加热蒸汽冷凝回收 ; (4) 将步骤 (1)的粉末的另一半放入白芷中, 在 60摄氏度的环境下加热 2.5小 吋, 取出药汁; (5) 将步骤 (4) 完成的药汁和步骤 (3) 中冷凝回收的冷凝液 进行混合, 混合后二次加热搅拌; (6) 将步骤 (5) 得到的混溶液中加入炒麦 芽, 搅拌后在 50摄氏度的温度下加热, 去除水分后将糊状混合物捏成丸状后蜡 封。 [0006] A method for preparing a proprietary Chinese medicine for gastroenteritis is prepared by the following steps: (1) Rhodiola, Viola, Apocynum venetum, dog ridge, wild chrysanthemum, eucalyptus, rehmannia and The floating wheat is ground into a powder and stirred evenly; (2) Take half of the mixed powder of step (1) into distilled water and soak for 30-60 hours; (3) heat the aqueous solution completed in step (2), the heating temperature is low. At 80 ° C, the heated steam is condensed and recovered; (4) The other half of the powder of step (1) is placed in a chalk, heated at 60 ° C for 2.5 hours, and the juice is removed; (5) Step (4) The completed juice is mixed with the condensate recovered in the step (3), and then mixed and stirred twice; (6) The mixed solution obtained in the step (5) is added with fried malt, and stirred at a temperature of 50 ° C. After heating, after removing moisture, the paste mixture is kneaded into a pellet and then wax-sealed.
发明的有益效果 Advantageous effects of the invention
有益效果 Beneficial effect
[0007] 本发明的中成药组方来源于常用中药组分, 且多为药食两用之品, 原料价廉, 制备简单, 使用方便, 经多年临床应用和药理研究, 对治疗肠易激综合征、 功
能性消化不良、 功能性腹胀、 功能性便秘等胃肠道功能性病变具有显著的疗效 ; 原料药共奏消食和胃、 降逆止呕、 行气消积、 疏肝下气之功效, 针对各种原 因引起的胃肠炎均具有良好的疗效; 鉴于该病发病人数众多, 且本发明的中成 药具有无毒、 可长期服用的特点, 因此, 具有广阔的市场前景。 [0007] The Chinese patent medicine group of the invention is derived from commonly used traditional Chinese medicine components, and is mostly a medicine and food product, the raw material is cheap, the preparation is simple, the use is convenient, and after many years of clinical application and pharmacological research, the treatment of intestinal irritation Syndrome, work Gastrointestinal functional lesions such as dyspepsia, functional bloating, and functional constipation have significant curative effects; the drug substance plays a role in eliminating digestion and stomach, reducing vomiting, venting qi, eliminating liver and qi, Gastroenteritis caused by various reasons has a good curative effect; in view of the large number of cases of the disease, and the proprietary Chinese medicine of the present invention has the characteristics of being non-toxic and can be taken for a long time, it has broad market prospects.
实施该发明的最佳实施例 BEST MODE FOR CARRYING OUT THE INVENTION
本发明的最佳实施方式 BEST MODE FOR CARRYING OUT THE INVENTION
[0008] 实施例 1本发明为一种用于胃肠炎的中成药, 由以下重量份数的原料制成: 红 景天 10份、 紫背天葵 8份、 罗布麻叶 5份、 狗脊 5份、 野菊花 3份、 楹树 5份、 炒麦 芽 10份、 熟地 3份、 浮小麦 2份、 白芷 150份。 一种用于胃肠炎的中成药的制作方 法, 由以下步骤制成: (1) 红景天、 紫背天葵、 罗布麻叶、 狗脊、 野菊花、 楹 树、 熟地和浮小麦研磨成粉末, 搅拌均匀; (2) 取一半步骤 (1) 的混合粉末 放入蒸馏水中, 浸泡 45小吋; (3) 将步骤 (2) 完成的水溶液进行加热, 加热 温度为 75摄氏度, 将加热蒸汽冷凝回收; (4) 将步骤 (1)的粉末的另一半放入白 芷中, 在 60摄氏度的环境下加热 2.5小吋, 取出药汁; (5) 将步骤 (4) 完成的 药汁和步骤 (3) 中冷凝回收的冷凝液进行混合, 混合后二次加热搅拌; (6) 将步骤 (5) 得到的混溶液中加入炒麦芽, 搅拌后在 50摄氏度的温度下加热, 去 除水分后将糊状混合物捏成丸状后蜡封。 [0008] Example 1 The present invention is a proprietary Chinese medicine for gastroenteritis, which is prepared from the following raw materials by weight: 10 parts of Rhodiola, 8 parts of Viola, and 5 parts of Apocynum venetum L., dog 5 parts of ridge, 3 parts of wild chrysanthemum, 5 parts of eucalyptus, 10 parts of fried malt, 3 parts of cooked land, 2 parts of floating wheat, and 150 parts of white peony. A method for preparing a proprietary Chinese medicine for gastroenteritis, which is prepared by the following steps: (1) Rhodiola, purple-backed sunflower, Apocynum venetum, dog ridge, wild chrysanthemum, eucalyptus, radix and floating wheat Powder, stir well; (2) Take half of the mixed powder of step (1) into distilled water and soak for 45 hours; (3) Heat the aqueous solution completed in step (2), heat at 75 ° C, and heat Steam condensation recovery; (4) Put the other half of the powder of step (1) into the chalk, heat it at 60 °C for 2.5 hours, and remove the juice; (5) Prepare the juice of step (4) and In step (3), the condensate recovered by condensation is mixed, and then mixed and stirred under heating; (6) adding the fried malt to the mixed solution obtained in the step (5), stirring and heating at a temperature of 50 ° C to remove water. The paste mixture was kneaded into a pellet and then wax sealed.
[0009] 为了更好地说明本发明, 下面通过本发明药物治疗慢性胃肠疾病 100例临床验 证病例总结进一步阐述本发明药物的有益效果。 以下试验中所用本发明药物按 照实施例 1方法制备。 In order to better illustrate the present invention, the beneficial effects of the medicament of the present invention are further illustrated by the summary of clinically validated cases of 100 cases of chronic gastrointestinal diseases treated with the medicament of the present invention. The medicament of the present invention used in the following test was prepared in accordance with the method of Example 1.
[0010] 一、 观察方法 [0010] First, the observation method
[0011] (一)观察对象: 本组病例均为青岛市海慈医院门诊患者, 未经治疗或治疗不愈 者, 包括功能性腹泻, 功能性消化不良, 肠易激综合征, 慢性感染性腹泻均为 观察对象。 [0011] (1) Observing subjects: This group of patients are outpatients of Qingdao Haici Hospital, including untreated or untreated, including functional diarrhea, functional dyspepsia, irritable bowel syndrome, chronic infectivity Diarrhea is the subject of observation.
[0012] (二)诊断标准 [0012] (two) diagnostic criteria
[0013] 采用 《1999年罗马 II标准》 , 所选病例符合功能性腹泻、 功能性消化不良、 肠 易激综合征、 慢性感染性腹泻的诊断标准。 所有病例均经胃、 结肠内镜或 X线 钡剂造影检査, 排除胃、 十二指肠、 结肠器质性病变。
[0014] (三)剔除标准 [0013] Using the "Roman II Standard 1999", the selected cases met the diagnostic criteria for functional diarrhea, functional dyspepsia, irritable bowel syndrome, and chronic infectious diarrhea. All cases were examined by gastric, colon endoscopy or X-ray barium angiography to exclude gastric, duodenal and colonic organic lesions. [0014] (3) Exclusion criteria
[0015] 1、 有器质性消化系统疾病者, 如息肉, 肿瘤等。 2、 有肝肾, 内分泌, 免疫系 统及血液系统严重原发病者: 糖尿病, 尿毒症, 肝病等。 3、 孕妇及哺乳期妇女 。 4、 不符合诊断标准的。 [0015] 1, there are organic digestive diseases, such as polyps, tumors and so on. 2, there are liver and kidney, endocrine, immune system and severe primary disease of the blood system: diabetes, uremia, liver disease and so on. 3. Pregnant women and lactating women. 4. Does not meet the diagnostic criteria.
[0016] (四)症状程度评定标准 [0016] (four) symptom level assessment criteria
[0017] 参照 《中药新药临床指导原则》 : 根据症状的轻、 中、 重度分别记 1、 2、 3分 [0017] Refer to "Clinical Guidelines for New Drugs of Traditional Chinese Medicine": According to the light, medium and severe symptoms, score 1, 2, 3
[0018] 1、 症状计分法: (1)无症状 (-): 记 0分; (2)轻度 (+) : 偶尔出现记 1分; [0019] (3)中度 (++) : 经常出现记 2分; (4)重度 (+++) : 持续存在记 3分。 [0018] 1. Symptom scoring method: (1) Asymptomatic (-): 0 points; (2) Mild (+): Occasionally 1 point; [0019] (3) Moderate (++) : 2 points are often recorded; (4) Severe (+++): 3 points are persisted.
[0020] 2、 泄泻: [0020] 2, diarrhea:
[0021] (1)无症状及成形软变 (-) : 每日 1-2次记 0分; (2)轻度 (+) : 症状轻微, 不影 响生活和工作, 能够忍受, 大便每日 2-3次, 糊状便或粘液便记 1分; (3) 中度 (++) : 症状较重, 已影响工作、 生活, 尚能忍受, 大便呈蛋花样, 每日 4-5 次, 或粘液便中等量记 2分; (4)重度 (+++) : 症状严重, 妨碍工作与生活, 难 以忍受, 稀水样便, 每日 6次以上, 或粘液便大量记 3分。 [0021] (1) Asymptomatic and softening (-): 0 points per day 1-2 times; (2) Mild (+): mild symptoms, does not affect life and work, can endure, stool daily 2-3 times, 1 point for paste or mucus; (3) Moderate (++): The symptoms are heavy, have affected work and life, can still bear, stool is egg pattern, 4-5 times a day , or mucus will be moderately recorded 2 points; (4) severe (+++): severe symptoms, hinder work and life, unbearable, dilute watery stool, more than 6 times a day, or a large amount of 3 points of mucus.
[0022] 3、 疾病的程度判定标准 [0022] 3, the degree of disease determination criteria
[0023] (1)重度: 主要症状积分 =〉总积分的 70%; (2)中度: 30% < =主要症状积 分<总积分的 70% ; (3)轻度: 主要症状积分 < =总积分的 30%; [0023] (1) Severity: Main symptom score => 70% of total score; (2) Moderate: 30% < = Main symptom score < 70% of total score; (3) Mild: Main symptom score < = 30% of the total points;
[0024] (五)疗效判定标准及统计方法 [0024] (5) Efficacy criteria and statistical methods
[0025] 参照 《中药新药临床指导原则》 作为标准。 [0025] Refer to "Clinical Guiding Principles for New Drugs of Traditional Chinese Medicine" as a standard.
[0026] 1、 疗效判定标准: (1)治愈: 主要症状消失, 大便成形, 每日 1-2次, 疗效指 数为 100% ; (2)显效: 主要临床症状基本消失大便次数每日 2-3次, 75% < = 疗效指数< 100%; (3) [0026] 1, the efficacy criteria: (1) cure: the main symptoms disappear, stool formation, 1-2 times a day, the efficacy index is 100%; (2) markedly effective: the main clinical symptoms basically disappeared stool times daily 2 3 times, 75% < = efficacy index < 100%; (3)
有效: 主要临床症状好转, 大便形状及次数均有好转, 30% < =疗效指数< 75 Effective: The main clinical symptoms improved, the shape and frequency of stool improved, 30% < = efficacy index < 75
0/ 0/
/0; /0;
[0027] (4)无效: 主要临床症状无改变, 疗效指数< 30%; 疾病疗效指数 = (治疗前 主要症状总分值-治疗后主要症状总分值) /治疗前主要症状总分值 χΐοο%。 [0027] (4) Invalid: No major changes in clinical symptoms, efficacy index < 30%; disease efficacy index = (total score of main symptoms before treatment - total score of main symptoms after treatment) / total score of main symptoms before treatment χΐοο %.
[0028] 2、 单项症状疗效评价标准:
[0029] (1)治愈: 疗程结束后, 症状消失; (2)显效: 疗效结束后, 症状分级减少 2级 [0028] 2. Evaluation criteria for single symptom efficacy: [0029] (1) Cure: After the end of the treatment, the symptoms disappear; (2) markedly effective: After the end of the curative effect, the symptom grade is reduced by 2
[0030] (3)有效: 疗效结束后, 症状分级减少 1级; (4)无效: 达不到上述标准。 [0030] (3) Effective: After the end of the curative effect, the symptom grade is reduced by 1 level; (4) Invalid: The above criteria are not met.
[0031] (六)观察指标 [0031] (6) Observation indicators
[0032] 1、 疗效性观察: [0032] 1, curative observation:
[0033] (1)治疗前、 疗程中症状和体征的变化。 (2)每日大便次数、 量。 [0033] (1) Changes in symptoms and signs before and during treatment. (2) The number and amount of daily stools.
[0034] (3)大便形状, 如脓血便、 粘液便和稀水便等。 (4)大便常规检査: 大便中红细 胞、 白细胞和脓细胞数量, 有无不消化食物纤维、 脂肪滴等。 (5)部分病人做便 培养。 (6)部分病人做结肠镜、 肠造影, 胃镜。 [0034] (3) stool shape, such as pus and bloody stools, mucus and thin water. (4) routine examination of stool: the number of red blood cells, white blood cells and pus cells in the stool, whether or not to digest food fiber, fat droplets, etc. (5) Some patients do the training. (6) Some patients underwent colonoscopy, intestinal angiography, and gastroscope.
[0035] 3、 安全性观察: [0035] 3. Security observation:
[0036] (1)血、 尿常规检査。 (2)便常规化验。 [0036] (1) Blood and urine routine examination. (2) routine testing.
[0037] 4、 主要临床症状观察: [0037] 4, the main clinical symptoms observed:
[0038] (1)功能性腹泻: 腹泻、 伴有里急后重、 水样便、 粘液便。 (2)功能性消化不良 : 上腹饱胀、 早饱、 嗳气、 上腹疼痛、 恶心呕吐、 反酸。 (3)肠易激综合征: 腹 痛、 腹胀、 腹泻、 便不尽、 大便次数、 形状。 (4)慢性感染性腹泻: 腹泻、 腹痛 、 里急后重、 粘液浓血便。 [0038] (1) Functional diarrhea: diarrhea, accompanied by urgency, watery stools, mucus. (2) Functional dyspepsia: upper abdominal fullness, early satiety, hernia, upper abdominal pain, nausea and vomiting, acid reflux. (3) Irritable bowel syndrome: abdominal pain, bloating, diarrhea, incontinence, stool frequency, shape. (4) Chronic infectious diarrhea: diarrhea, abdominal pain, urgency and heavy, mucus and blood.
[0039] 二、 临床资料 [0039] Second, clinical data
[0040] 治疗方法 [0040] Treatment method
[0041] 全部病例在用药期间停用其他治疗药物, 单纯使用本发明药物, 用法用量为 2 粒 /次, 3次 /日, 疗程为 4周。 [0041] In all cases, other therapeutic drugs were discontinued during the administration, and the drug of the present invention was used alone, and the dosage was 2 capsules/time, 3 times/day, and the course of treatment was 4 weeks.
[0042] 统计学方法 Statistical method
[0043] 计数资料应用 X2检验、 计量资料应用 t检验。 [0043] The count data is applied to the X2 test, and the measurement data is applied to the t test.
[0044] 观察结果 [0044] Observation results
[0045] 1、 各病种临床治疗前后总疗效观察, 如表 1所示 [0045] 1. The total curative effect of each disease before and after clinical treatment, as shown in Table 1.
[0046] 表 1各病种临床治疗前后总疗效表 [0046] Table 1 total efficacy table before and after clinical treatment of various diseases
[]
[表 1] [] [Table 1]
[0047] 2、 各病种临床治疗前后显效率比较情况, 如表 2所示 [0047] 2. Comparison of the effective efficiency before and after clinical treatment of various diseases, as shown in Table 2
[0048] 表 2各病种临床治疗前后显效率比较表 [0048] Table 2 Comparison of the apparent efficiency of each disease before and after clinical treatment
[]
[表 2] [] [Table 2]
[0049] 表明该药对上述 4种病均有显著的治疗作用。 [0049] It is indicated that the drug has a significant therapeutic effect on the above four diseases.
[0050] 三、 结果显示 [0050] Third, the result display
[0051] 1、 本发明的中成药对各种慢性胃肠疾病具有良好的治疗作用 [0051] 1. The Chinese patent medicine of the invention has a good therapeutic effect on various chronic gastrointestinal diseases.
[0052] 临床结果表明, 本发明药物治疗慢性胃肠疾病的各病种效果统计学无显著性差 异, 说明对各种慢性胃肠疾病均有很好的治疗作用。 [0052] The clinical results show that there is no statistically significant difference in the effect of the drug of the present invention for treating chronic gastrointestinal diseases, indicating that it has a good therapeutic effect on various chronic gastrointestinal diseases.
[0053] 2、 具有明显改善慢性胃肠疾病患者临床症状的作用 [0053] 2. It has the effect of significantly improving the clinical symptoms of patients with chronic gastrointestinal diseases.
[0054] 临床结果表明, 本发明药物能明显缓解临床症状。 对单病种主症的改善效果明 显, 总有效率均在 85%以上。 [0054] Clinical results indicate that the medicament of the present invention can significantly alleviate clinical symptoms. The improvement effect on single disease main symptoms is obvious, and the total effective rate is above 85%.
[0055] 3、 用药期间未发现明显副作用。 [0055] 3. No significant side effects were found during the medication.
本发明的实施方式 Embodiments of the invention
[0056] 实施例 2本发明为一种用于胃肠炎的中成药, 由以下重量份数的原料制成: 红 景天 17份、 紫背天葵 10份、 罗布麻叶 10份、 狗脊 10份、 野菊花 7份、 楹树 9份、 炒麦芽 15份、 熟地 6份、 浮小麦 6份、 白芷 200份。 一种用于胃肠炎的中成药的制 作方法, 由以下步骤制成: (1) 红景天、 紫背天葵、 罗布麻叶、 狗脊、 野菊花 、 楹树、 熟地和浮小麦研磨成粉末, 搅拌均匀; (2) 取一半步骤 (1) 的混合 粉末放入蒸馏水中, 浸泡 30小吋; (3) 将步骤 (2) 完成的水溶液进行加热,
加热温度为 78摄氏度, 将加热蒸汽冷凝回收; (4) 将步骤 (1)的粉末的另一半放 入 180份的白芷中, 在 60摄氏度的环境下加热 2.5小吋, 取出药汁; (5) 将步骤 (4) 完成的药汁和步骤 (3) 中冷凝回收的冷凝液进行混合, 混合后二次加热 搅拌; (6) 将步骤 (5) 得到的混溶液中加入炒麦芽, 搅拌后在 50摄氏度的温 度下加热, 去除水分后将糊状混合物捏成丸状后蜡封。 [Example 2] The present invention is a proprietary Chinese medicine for gastroenteritis, which is prepared from the following raw materials by weight: Rhodiola 17 parts, Purple geranium 10 parts, Apocynum venetum 10 parts, dog 10 parts of ridges, 7 parts of wild chrysanthemums, 9 parts of eucalyptus, 15 parts of fried malt, 6 parts of cooked land, 6 parts of floating wheat, and 200 parts of white peony. A method for preparing a proprietary Chinese medicine for gastroenteritis, which is prepared by the following steps: (1) Rhodiola, purple-backed sunflower, Apocynum venetum, dog ridge, wild chrysanthemum, eucalyptus, radix and floating wheat Powder, stir well; (2) Take half of the mixed powder of step (1) into distilled water, soak for 30 hours; (3) Heat the aqueous solution completed in step (2), The heating temperature is 78 degrees Celsius, and the heated steam is condensed and recovered; (4) The other half of the powder of the step (1) is placed in 180 parts of white peony, heated at 60 degrees Celsius for 2.5 hours, and the medicinal juice is taken out; Mixing the juice completed in step (4) with the condensate recovered in step (3), mixing and heating and stirring; (6) adding the fried malt to the mixed solution obtained in step (5), stirring The mixture was heated at a temperature of 50 ° C, and after removing moisture, the paste mixture was kneaded into a pellet and then wax-sealed.
[0057] 实施例 3本发明为一种用于胃肠炎的中成药, 由以下重量份数的原料制成: 红 景天 13份、 紫背天葵 9份、 罗布麻叶 7份、 狗脊 7.5份、 野菊花 4.5份、 楹树 7.5份、 炒麦芽 13份、 熟地 5份、 浮小麦 4.2份、 白芷 180份。 一种用于胃肠炎的中成药的 制作方法, 由以下步骤制成: (1) 红景天、 紫背天葵、 罗布麻叶、 狗脊、 野菊 花、 楹树、 熟地和浮小麦研磨成粉末, 搅拌均匀; (2) 取一半步骤 (1) 的混 合粉末放入蒸馏水中, 浸泡 60小吋; (3) 将步骤 (2) 完成的水溶液进行加热 , 加热温度为 70摄氏度, 将加热蒸汽冷凝回收; (4) 将步骤 (1)的粉末的另一半 放入 180份的白芷中, 在 60摄氏度的环境下加热 2.5小吋, 取出药汁; (5) 将步 骤 (4) 完成的药汁和步骤 (3) 中冷凝回收的冷凝液进行混合, 混合后二次加 热搅拌; (6) 将步骤 (5) 得到的混溶液中加入炒麦芽, 搅拌后在 50摄氏度的 温度下加热, 去除水分后将糊状混合物捏成丸状后蜡封。 [Example 3] The present invention is a proprietary Chinese medicine for gastroenteritis, which is prepared from the following raw materials by weight: 13 parts of Rhodiola, 9 parts of Viola, and 7 parts of Apocynum venetum L., dog 7.5 parts of ridges, 4.5 parts of wild chrysanthemums, 7.5 parts of eucalyptus, 13 parts of fried malt, 5 parts of cooked land, 4.2 parts of floating wheat, and 180 parts of white peony. A method for preparing a proprietary Chinese medicine for gastroenteritis, which is prepared by the following steps: (1) Rhodiola, purple-backed sunflower, Apocynum venetum, dog ridge, wild chrysanthemum, eucalyptus, radix and floating wheat Powder, stir evenly; (2) Take half of the mixed powder of step (1) into distilled water and soak for 60 hours; (3) Heat the aqueous solution completed in step (2), heat at 70 ° C, and heat Steam condensation recovery; (4) Put the other half of the powder of step (1) into 180 parts of white peony, heat it at 60 degrees Celsius for 2.5 hours, and remove the medicinal juice; (5) Complete the step (4) The medicinal juice is mixed with the condensate recovered by the condensation in the step (3), and then mixed and heated and stirred twice; (6) adding the fried malt to the mixed solution obtained in the step (5), stirring and heating at a temperature of 50 ° C. After removing the moisture, the paste mixture was kneaded into a pellet and then wax-sealed.
工业实用性 Industrial applicability
[0058] 当然, 上述说明并非是对本发明的限制, 本发明也并不限于上述举例, 本技术 领域的普通技术人员, 在本发明的实质范围内, 作出的变化、 改型、 添加或替 换, 都应属于本发明的保护范围。 The above description is of course not a limitation of the present invention, and the present invention is not limited to the above examples, and variations, modifications, additions or substitutions made by those skilled in the art within the scope of the present invention, All should fall within the scope of protection of the present invention.
[0059]
[0059]
Claims
[权利要求 1] 一种用于胃肠炎的中成药, 其特征在于: 由以下重量份数的原料制成 : 红景天 10-17份、 紫背天葵 8-10份、 罗布麻叶 5-10份、 狗脊 5-10份、 野菊花 3-7份、 楹树 5-9份、 炒麦芽 10-15份、 熟地 3-6份、 浮小麦 2-6份 、 白芷 150-200份。 [Claim 1] A proprietary Chinese medicine for gastroenteritis, which is characterized in that it is made of the following raw materials by weight: 10-17 parts of Rhodiola, 8-10 parts of Viola, and Apocynum venetum leaves 5-10 parts, 5-10 parts of dog ridge, 3-7 parts of wild chrysanthemum, 5-9 parts of eucalyptus, 10-15 parts of fried malt, 3-6 parts of cooked land, 2-6 parts of floating wheat, 150-200 of white peony Share.
[权利要求 2] 根据权利要求 1所述的用于胃肠炎的中成药, 其特征在于: 由以下重 量份数的原料制成: 红景天 12-14份、 紫背天葵 8.5-9.5份、 罗布麻叶 6. 5-7.5份、 狗脊 7-9份、 野菊花 4-6份、 楹树 6-8份、 炒麦芽 12- 14份、 熟 地 4.5-5.5份、 浮小麦 3-5.5份、 白芷 160-190份。 [Claim 2] The Chinese patent medicine for gastroenteritis according to claim 1, which is prepared from the following raw materials by weight: 12-14 parts of Rhodiola, 8.5-9.5 5.4 parts of Apocynum venetum L., 5-7.5 parts of dog's ridge, 7-9 parts of dog ridge, 4-6 parts of wild chrysanthemum, 6-8 parts of eucalyptus, 12-14 parts of fried malt, 4.5-5.5 parts of cooked land, floating wheat 3- 5.5 parts, 160-190 parts of white peony.
[权利要求 3] 根据权利要求 1所述的用于胃肠炎的中成药, 其特征在于: 由以下重 量份数的原料制成: 红景天 13份、 紫背天葵 9份、 罗布麻叶 7份、 狗脊 7.5份、 野菊花 4.5份、 楹树 7.5份、 炒麦芽 13份、 熟地 5份、 浮小麦 4.2 份、 、 白芷 180份。 [Claim 3] The Chinese patent medicine for gastroenteritis according to claim 1, which is prepared from the following raw materials by weight: 13 parts of Rhodiola, 9 parts of Viola, and Apocynum venetum 7 parts of leaves, 7.5 parts of dog ridges, 4.5 parts of wild chrysanthemums, 7.5 parts of eucalyptus, 13 parts of fried malt, 5 parts of cooked land, 4.2 parts of floating wheat, and 180 parts of white peony.
[权利要求 4] 一种权利要求 1-3中任意一项的用于胃肠炎的中成药的制作方法, 其 特征在于: 由以下步骤制成: (1) 红景天、 紫背天葵、 罗布麻叶、 狗脊、 野菊花、 楹树、 熟地和浮小麦研磨成粉末, 搅拌均匀; (2) 取一半步骤 (1) 的混合粉末放入蒸馏水中, 浸泡 30-60小吋; (3) 将步骤 (2) 完成的水溶液进行加热, 加热温度低于 80摄氏度, 将加 热蒸汽冷凝回收; (4) 将步骤 (1)的粉末的另一半放入白芷中, 在 60 摄氏度的环境下加热 2.5小吋, 取出药汁; (5) 将步骤 (4) 完成的 药汁和步骤 (3) 中冷凝回收的冷凝液进行混合, 混合后二次加热搅 拌; (6) 将步骤 (5) 得到的混溶液中加入炒麦芽, 搅拌后在 50摄氏 度的温度下加热, 去除水分后将糊状混合物捏成丸状后蜡封。
[Claim 4] A method for producing a proprietary Chinese medicine for gastroenteritis according to any one of claims 1 to 3, characterized in that it is produced by the following steps: (1) Rhodiola rosea , apocynum venetum, dog ridge, wild chrysanthemum, eucalyptus, cultivar and floating wheat are ground into powder and stirred evenly; (2) Take half of the mixed powder of step (1) into distilled water and soak for 30-60 hours; 3) The aqueous solution completed in the step (2) is heated, the heating temperature is lower than 80 degrees Celsius, and the heated steam is condensed and recovered; (4) the other half of the powder of the step (1) is placed in a white crucible at 60 degrees Celsius. After heating for 2.5 hours, remove the juice; (5) Mix the juice completed in step (4) with the condensate recovered in step (3), mix and stir with heating; (6) Step (5) The obtained mixed solution was added with fried malt, stirred and heated at a temperature of 50 ° C. After removing the water, the paste mixture was kneaded into a pellet and then wax-sealed.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201511011384.8 | 2015-12-30 | ||
CN201511011384.8A CN105535695A (en) | 2015-12-30 | 2015-12-30 | Chinese patent medicine for treating gastroenteritis and preparation method thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2017114372A1 true WO2017114372A1 (en) | 2017-07-06 |
Family
ID=55815581
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/CN2016/112236 WO2017114372A1 (en) | 2015-12-30 | 2016-12-27 | Chinese patent medicine for treating gastroenteritis and preparation method therefor |
Country Status (2)
Country | Link |
---|---|
CN (1) | CN105535695A (en) |
WO (1) | WO2017114372A1 (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105535695A (en) * | 2015-12-30 | 2016-05-04 | 张鹏 | Chinese patent medicine for treating gastroenteritis and preparation method thereof |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1437987A (en) * | 2002-09-16 | 2003-08-27 | 彭申健 | Weibingkang for treating stomach disease and preparation method |
CN102319412A (en) * | 2011-09-27 | 2012-01-18 | 解连新 | Traditional Chinese medicine used for treating diarrhea |
CN103550737A (en) * | 2013-10-31 | 2014-02-05 | 谢坤 | Traditional Chinese medicinal composition for treating diarrhea |
CN104666438A (en) * | 2015-03-13 | 2015-06-03 | 朱晓岩 | Chinese patent medicine for treating chronic gastric disease of spleen deficiency and preparation method of Chinese patent medicine |
CN104771745A (en) * | 2015-04-28 | 2015-07-15 | 臧孝国 | Traditional Chinese medicine composition for treating diarrhea, preparation method and application thereof |
CN105535695A (en) * | 2015-12-30 | 2016-05-04 | 张鹏 | Chinese patent medicine for treating gastroenteritis and preparation method thereof |
-
2015
- 2015-12-30 CN CN201511011384.8A patent/CN105535695A/en active Pending
-
2016
- 2016-12-27 WO PCT/CN2016/112236 patent/WO2017114372A1/en active Application Filing
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1437987A (en) * | 2002-09-16 | 2003-08-27 | 彭申健 | Weibingkang for treating stomach disease and preparation method |
CN102319412A (en) * | 2011-09-27 | 2012-01-18 | 解连新 | Traditional Chinese medicine used for treating diarrhea |
CN103550737A (en) * | 2013-10-31 | 2014-02-05 | 谢坤 | Traditional Chinese medicinal composition for treating diarrhea |
CN104666438A (en) * | 2015-03-13 | 2015-06-03 | 朱晓岩 | Chinese patent medicine for treating chronic gastric disease of spleen deficiency and preparation method of Chinese patent medicine |
CN104771745A (en) * | 2015-04-28 | 2015-07-15 | 臧孝国 | Traditional Chinese medicine composition for treating diarrhea, preparation method and application thereof |
CN105535695A (en) * | 2015-12-30 | 2016-05-04 | 张鹏 | Chinese patent medicine for treating gastroenteritis and preparation method thereof |
Also Published As
Publication number | Publication date |
---|---|
CN105535695A (en) | 2016-05-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN100518810C (en) | Chinese medicinal composition for treating gastroesophageal reflux disease | |
CN116747274B (en) | Traditional Chinese medicine composition and preparation for treating gastroesophageal reflux disease with syndrome of liver-stomach stagnation heat and application of traditional Chinese medicine composition and preparation | |
CN100360165C (en) | Powder for treating stomach-ache and preparing method | |
WO2017114372A1 (en) | Chinese patent medicine for treating gastroenteritis and preparation method therefor | |
CN103356880B (en) | Chinese patent medicine for promoting gastrointestinal motility and its preparation method | |
CN105832991A (en) | Traditional Chinese medicine composition for treating gastritis | |
CN105213991B (en) | Traditional Chinese medicine composition for treating gastroesophageal reflux disease | |
CN110327435B (en) | Traditional Chinese medicine composition for treating ulcerative colitis and chronic proctitis and application thereof | |
CN1148217C (en) | Chinese medicine for treating chronic bronchitis | |
CN103877384B (en) | A kind of Chinese medicine preparation and preparation method who treats the carcinoma of the rectum | |
CN105617335A (en) | Radix bupleurum Xianxiong decoction capable of improving bile reflux gastritis after cancer chemoradiotherapy | |
CN104784650A (en) | Pharmaceutical preparation for clinical nursing of gastric ulcer | |
CN105853653B (en) | Pharmaceutical composition for treating chronic gastritis and preparation method thereof | |
CN103623283A (en) | Traditional Chinese medicine for treating phlegm-damp stagnation type gastric cancer and preparation method thereof | |
CN103705856B (en) | For preventing the Chinese medicine composition of chemicotherapy acute radio-reaction | |
CN103638280B (en) | For treating the Chinese medicine of reflux esophagitis | |
CN110038113B (en) | Traditional Chinese medicine composition and medicine for gastroesophageal reflux disease, and preparation method and application thereof | |
CN106938041A (en) | It is a kind of to treat Chinese medicine preparation of gastric ulcer and preparation method thereof and its medicinal usage | |
CN106421600A (en) | Chinese-Western medicine compound preparation for treating alimentary tract hemorrhage and preparation method | |
Jia et al. | Using Banxia Xiexin Decoction for Chronic Atrophic Gastritis | |
CN105031388A (en) | Medicine for treating alimentary tract hemorrhage and preparing method | |
CN102784206B (en) | Niweikang and preparation method thereof | |
CN104784651A (en) | Method for preparing pharmaceutical preparation for treating gastric ulcer | |
CN116832113A (en) | Traditional Chinese medicine composition and traditional Chinese medicine decoction for treating gastroesophageal reflux disease, and preparation method and application thereof | |
CN105125688B (en) | A kind of relieving haperacidity analgesic composition containing milk basic protein and preparation method thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 16881161 Country of ref document: EP Kind code of ref document: A1 |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 16881161 Country of ref document: EP Kind code of ref document: A1 |